Have a feature idea you'd love to see implemented?
Let us know!
NDRA ENDRA Life Sciences Inc
Price (delayed)
$0.3019
Market cap
$437,390
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$39.5
Enterprise value
-$5.68M
ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the
Highlights
NDRA's equity has surged by 143% since the previous quarter and by 30% year-on-year
The company's quick ratio has surged by 100% YoY
Key stats
What are the main financial stats of NDRA
Market
Valuations
Earnings
Shares outstanding
1.45M
Market cap
$437,390
Enterprise value
-$5.68M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.01
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$9.57M
EBITDA
-$9.33M
Free cash flow
-$9.01M
Per share
Balance sheet
Liquidity
EPS
-$39.5
Free cash flow per share
-$16.51
Book value per share
$40.75
Revenue per share
$0
TBVPS
$19.14
Total assets
$10.44M
Total liabilities
$1.45M
Debt
$281,154
Equity
$8.99M
Working capital
$5.36M
Debt to equity
0.03
Current ratio
4.97
Quick ratio
4.74
Net debt/EBITDA
0.66
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-128.1%
Return on equity
-162.5%
Return on invested capital
-320.2%
Return on capital employed
-105.2%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
NDRA stock price
How has the ENDRA Life Sciences stock price performed over time
Intraday
-8.52%
1 week
46.48%
1 month
38.8%
1 year
-99.39%
YTD
-99.72%
QTD
50.2%
Financial performance
How have ENDRA Life Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$9.17M
Net income
-$9.57M
Gross margin
N/A
Net margin
N/A
The operating income rose by 28% year-on-year and by 8% since the previous quarter
ENDRA Life Sciences's net income has increased by 22% YoY and by 3.3% from the previous quarter
Growth
What is ENDRA Life Sciences's growth rate over time
Valuation
What is ENDRA Life Sciences stock price valuation
P/E
N/A
P/B
0.01
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The company's EPS has surged by 77% YoY and by 31% QoQ
NDRA's equity has surged by 143% since the previous quarter and by 30% year-on-year
NDRA's P/B is 100% less than its 5-year quarterly average of 3.4 and 99% less than its last 4 quarters average of 1.7
Efficiency
How efficient is ENDRA Life Sciences business performance
The company's return on invested capital rose by 20% YoY and by 4.2% QoQ
The return on equity has grown by 12% since the previous quarter and by 4.2% year-on-year
The ROA has increased by 7% since the previous quarter
Dividends
What is NDRA's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for NDRA.
Financial health
How did ENDRA Life Sciences financials performed over time
NDRA's total assets has soared by 106% since the previous quarter and by 13% year-on-year
The company's quick ratio has surged by 100% YoY
The debt is 97% less than the equity
NDRA's equity has surged by 143% since the previous quarter and by 30% year-on-year
The debt to equity has shrunk by 67% QoQ and by 57% YoY
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.